Literature DB >> 16365395

Integrin alphaIIbbeta3 induces the adhesion and activation of mast cells through interaction with fibrinogen.

Toshihiko Oki1, Jiro Kitaura, Koji Eto, Yang Lu, Mari Maeda-Yamamoto, Naoki Inagaki, Hiroichi Nagai, Yoshinori Yamanishi, Hideaki Nakajima, Hideaki Nakajina, Hidetoshi Kumagai, Toshio Kitamura.   

Abstract

Integrin alphaIIb, a well-known marker of megakaryocyte-platelet lineage, has been recently recognized on hemopoietic progenitors. We now demonstrate that integrin alphaIIbbeta3 is highly expressed on mouse and human mast cells including mouse bone marrow-derived mast cells, peritoneal mast cells, and human cord blood-derived mast cells, and that its binding to extracellular matrix proteins leads to enhancement of biological functions of mast cells in concert with various stimuli. With exposure to various stimuli, including cross-linking of FcepsilonRI and stem cell factor, mast cells adhered to extracellular matrix proteins such as fibrinogen and von Willebrand factor in an integrin alphaIIbbeta3-dependent manner. In addition, the binding of mast cells to fibrinogen enhanced proliferation, cytokine production, and migration and induced uptake of soluble fibrinogen in response to stem cell factor stimulation, implicating integrin alphaIIbbeta3 in a variety of mast cell functions. In conclusion, mouse and human mast cells express functional integrin alphaIIbbeta3.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365395     DOI: 10.4049/jimmunol.176.1.52

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Kounis syndrome (allergic acute coronary syndrome): different views in allergologic and cardiologic literature.

Authors:  Filippo Fassio; Fabio Almerigogna
Journal:  Intern Emerg Med       Date:  2012-01-22       Impact factor: 3.397

2.  Evidence that integrin alpha IIb beta 3-dependent interaction of mast cells with fibrinogen exacerbates chronic inflammation.

Authors:  Toshihiko Oki; Koji Eto; Kumi Izawa; Yoshinori Yamanishi; Naoki Inagaki; Jon Frampton; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

Review 3.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

Review 4.  Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Authors:  Jennifer Yeung; Wenjie Li; Michael Holinstat
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

5.  Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships.

Authors:  K Ding; D Feng; M de Andrade; T H Mosley; S T Turner; E Boerwinkle; I J Kullo
Journal:  J Hum Hypertens       Date:  2007-10-25       Impact factor: 3.012

6.  The a1/a2 polymorphism of the glycoprotein IIIa gene and myocardial infarction in Caucasians with type 2 diabetes.

Authors:  Jovana Nikolajević-Starčević; Daniel Petrovič
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

Review 7.  Tetraspanins in the regulation of mast cell function.

Authors:  Zane Orinska; Philipp M Hagemann; Ivana Halova; Petr Draber
Journal:  Med Microbiol Immunol       Date:  2020-06-07       Impact factor: 3.402

Review 8.  The Art of Mast Cell Adhesion.

Authors:  Joanna Pastwińska; Paulina Żelechowska; Aurelia Walczak-Drzewiecka; Ewa Brzezińska-Błaszczyk; Jarosław Dastych
Journal:  Cells       Date:  2020-12-11       Impact factor: 6.600

9.  Mast cells: pivotal players in cardiovascular diseases.

Authors:  Ilze Bot; Theo J C van Berkel; Erik A L Biessen
Journal:  Curr Cardiol Rev       Date:  2008-08

10.  PAI1 mediates fibroblast-mast cell interactions in skin fibrosis.

Authors:  Neha Pincha; Edries Yousaf Hajam; Krithika Badarinath; Surya Prakash Rao Batta; Tafheem Masudi; Rakesh Dey; Peter Andreasen; Toshiaki Kawakami; Rekha Samuel; Renu George; Debashish Danda; Paul Mazhuvanchary Jacob; Colin Jamora
Journal:  J Clin Invest       Date:  2018-03-26       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.